Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation
03/09/2020 | Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with high morbidity, mortality and healthcare usage.
Call to Action: Rural Health
02/10/2020 | Addressing the unique health needs of people in rural America is critical to achieving the AHA?s new 2030 impact goal for equitably increasing healthy life expectancy.
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.
HYPERTENSION | Live Tweet Chat | November 25, 2019
11/22/2019 | HYPERTENSION, Obesity, High Blood Pressure, and Physical Activity Determine Vascular Phenotype in Young Children
2019 Update to the 2018 Acute Ischemic Stroke Guidelines
10/30/2019 | This guideline update provides up-to-date comprehensive recommendations for the management and treatment of persons with acute arterial ischemic stroke.